NetworkNewsBreaks

WednesdayMar 11, 2020 9:36 am

NetworkNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) Announces Q4, Year End 2019 Financial Results

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, on Tuesday released its results for the fourth quarter and fiscal year ended December 31, 2019. Among the highlights, the company posted $3.25 million in quarterly revenue ($11.16 million for the year) consisting of hemp-derived product sales in Europe of $2.56 million ($9.88 million for the year) and sales from cannabis products in Canada of $0.69 million ($1.28 million for the year). “While 2019 was a challenging year for the entire sector, we have made significant progress on the operational front and adjusted our…

Continue Reading

WednesdayMar 11, 2020 9:17 am

NetworkNewsBreaks – Exro Technologies Inc. (CSE: XRO) (OTCQB: EXROF) Grants Incentive Stock Options

Exro Technologies (CSE: XRO) (OTCQB: EXROF) on Tuesday announced that the company has granted incentive stock options to some directors, officers, employees, and consultants to purchase a total of 735,000 EXROF shares at a price of $0.375 each, in accordance with the company’s stock option plan. All the options are subject to vesting provisions, and all shares issued through the exercise of an option will be subject to a four month and one day hold period from the date of grant. To view the full press release, visit http://nnw.fm/0BsyB About Exro Technologies Inc. Exro facilitates the transition to clean energy…

Continue Reading

TuesdayMar 10, 2020 12:33 pm

NetworkNewsBreaks – Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) Announces Resignation of Executive Officer and Director

Wonderfilm Media Corporation (TSX.V: WNDR) (OTCQB: WDRFF) on Monday announced that, effective March 9, 2020, Norman Tsui has resigned as its executive vice president, interim chief financial officer, corporate secretary and as a director of the Company. As a result, Wonderfilm is working to identify suitable candidates to replace Tsui. The Company thanks Mr. Tsui for his contributions, especially with regard to stepping in as the interim chief financial officer and working to resolve the Cease Trade Order against the Company, and wishes him well in his future endeavors. To view the full press release, visit http://nnw.fm/9dtLD About Wonderfilm Media…

Continue Reading

TuesdayMar 10, 2020 12:20 pm

NetworkNewsBreaks – CytoSorbents Corporation (NASDAQ: CTSO) Featured in Dawson James Research Report

CytoSorbents Corporation (NASDAQ: CTSO) was featured in a recent Institutional Research Report published by Dawson James Securities Inc. The report reads, “The company reported Q4 Revenues of $7.4M, $6.6M in cartridges vs. $5.7M in the prior qtr. Slow but steady growth, however we see the potential for revenues to rise with new indications. In fact, we believe CytoSorb sales have just scratched the surface of what’s possible. We are raising our price target from $15.00 to $17.00 per share.” To request access to the full report, visit http://nnw.fm/SB1bo About CytoSorbents Corporation CytoSorbents Corporation is a leader in critical care immunotherapy, specializing…

Continue Reading

TuesdayMar 10, 2020 12:10 pm

NetworkNewsBreaks – PDS Biotechnology Corp. (NASDAQ: PDSB) Featured in Noble Capital Markets Research Update

PDS Biotechnology Corp. (NASDAQ: PDSB) was featured in a recent equity research update published by Noble Capital Markets. The report reads, “PDS Biotechnology is developing a platform technology known as Versamune for the treatment of cancer. Versamune consists of cationic (positively charged) lipids mix with tumor or viral antigens. Cationic lipids act as a vehicle to deliver the antigens to dendritic cells, which mature and help inducing a potent T-cell driven anti-cancer immune response.” To view the update and gain access to the full report, visit http://nnw.fm/j8Byw About PDS Biotechnology Corp. PDS Biotech is a clinical-stage immuno-oncology company developing multiple therapies…

Continue Reading

TuesdayMar 10, 2020 12:03 pm

NetworkNewsBreaks – Mohawk Group Holdings, Inc. (NASDAQ: MWK) Featured in ROTH Equity Research Report

Mohawk Group Holdings, Inc. (NASDAQ: MWK) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We believe Mohawk is significantly disrupting several consumer product categories using its proprietary software platform: AIMEE. Mohawk uses data from e-commerce platforms to develop products in categories where it can dominate search results, while optimizing price, marketing, and fulfillment to generate product-level contribution margins of ~10%. We believe Mohawk has demonstrated the viability of this model and see a path to profitability ahead. We resume coverage of Mohawk at Buy with a $6 PT.” To request access…

Continue Reading

TuesdayMar 10, 2020 11:53 am

NetworkNewsBreaks – Pixelworks, Inc. (NASDAQ: PXLW) Featured in ROTH Equity Research Report

Pixelworks, Inc. (NASDAQ: PXLW) was featured in a recent equity research report published by ROTH Capital Partners LLC. The report reads, “We believe PXLW represents a differentiated investment opportunity in video display processing capabilities. We believe the Find X2 smartphones represent the first of several future OPPO smartphone models that will critically rely on PXLW’s Iris advanced video features to drive upgrade cycles. We expect PXLW’s to develop additional Tier-1 smartphone traction in the coming quarters. We maintain our Buy rating.” To request access to the full report, visit http://nnw.fm/DXCr3 About Pixelworks, Inc. Pixelworks provides industry-leading content creation, video delivery…

Continue Reading

TuesdayMar 10, 2020 11:41 am

NetworkNewsBreaks – Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) Featured in Mizuho Securities Research Report

Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We continue to recommend shares of CRVS based on our view that data can reset the company's valuation, and we see that visibility improving this year. The 4Q19 update call pointed to ASCO and SITC as key venues for data disclosures for ciforadenant (cifo) and CPI-006, respectively, which we believe could validate encouraging data and immuno-modulatory activity previously presented and bring clarity to the clinical path and commercial opportunity. Our FY20 EPS remains largely unchanged, now ($1.58) from…

Continue Reading

TuesdayMar 10, 2020 11:35 am

NetworkNewsBreaks – Arcus Biosciences, Inc. (NYSE: RCUS) Featured in Mizuho Securities Research Report

Arcus Biosciences, Inc. (NYSE: RCUS) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We like shares of RCUS based on the combinatorial approach to development of its immuno-oncology (I/O)-focused pipeline. The 4Q19 EPS update reaffirmed the development strategy for 2020, including catalysts for initial data for AB928+FOLFOX in mCRC (AACR) and preliminary randomization data from AB154 (anti-TIGIT) in 1st-line NSCLC. The shares have rallied this year based on interest in AB154, in our view, which is understandable following the external validation of the program via competitor advancement into Phase III, as…

Continue Reading

TuesdayMar 10, 2020 11:26 am

NetworkNewsBreaks – Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) Featured in Mizuho Securities Research Report

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “We applied a weighted average valuation (DCF and EV/Sales) to derive our $54 PT. Our assumptions include: Rhopressa: U.S. peak-sales of $162 mil in 2025. Rocklatan: U.S. peak-sales of $331 mil in 2025. DCF Assumptions: Terminal value of 5x 2028 FCF and a 11% discount rate to derive a$49 PT. EV/Sales Assumptions: 7x multiple of 2028 sales, discounted at 11% to derive a $58 PT. In our bull case scenario, we assume greater than anticipated market share of…

Continue Reading